George Feng

George Feng is a Biotech Investor at TCGX since August 2022, focusing on both public and private biotech sectors. Prior experience includes serving as an Academy Summer Analyst at Point72 in 2021, with a rotation on the therapeutics desk, and working in Capital Markets at CPP Investments in 2020. Additionally, George gained finance experience at Novartis in 2019. George holds a BSc in Engineering with a focus on Bioengineering from the University of Pennsylvania and a BSc in Economics with a concentration in Finance from The Wharton School. Education was initiated at Appleby College.